News
The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
A member of Columbia University's Board of Trustees is calling on the school to comply with the Trump administration's ...
Sheehan Brothers Vending is recalling numerous products due to an undeclared sesame allergen missing from the products' ...
The Senate Appropriations Committee sputtered Thursday as its consideration of the annual Justice Department funding bill was ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by ...
4h
News Nation on MSNModerna gets full FDA approval for kids COVID-19 vaccineThe company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results